PUBLISHER: iData Research Inc. | PRODUCT CODE: 1680157
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1680157
The global robotic-assisted orthopedic surgery system market was valued at $1.3 billion in 2024 and is projected to grow at a CAGR of 17.1%, reaching $3.9 billion by 2031.
The market is segmented into:
Market Insights & Data Coverage
Market Trends & Growth Drivers
Surge in Large Joint Replacement Procedures
* Zimmer Biomet received FDA clearance for its ROSA(R) Shoulder System in 2024 and successfully performed its first procedure.
* Stryker is expected to launch a Mako system for shoulder applications in the near future.
Geographic Trends & Growth Projections
Market Share Insights
Leading Competitors & Key Developments
1 Stryker - Market Leader
* Mako(TM) dominates the orthopedic robotic surgery market.
* Over 500,000 procedures globally using Mako(TM).
* Stryker also offers NAV3i(R) and NavSuite(R)3 navigation systems.
2 Smith & Nephew - Second-Largest Player
* Offers NAVIO(TM) and CORI(TM) surgical robots.
* CORI(TM) is the next-generation system that is replacing NAVIO(TM).
* Competes in both robotic-assisted surgery and orthopedic navigation.
3 Zimmer Biomet - Strong Contender
* ROSA(R) Robotics Portfolio includes:
* ROSA(R) Knee
* ROSA(R) Partial Knee
* ROSA(R) Hip
* ROSA(R) Shoulder (FDA approved in 2024)
Market Segmentation Summary
Global Research Scope
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia-Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
Quantitative Coverage
Qualitative Coverage
Data Sources